Low-Dose Methotrexate for the Prevention of Atherosclerotic Events

Authors

Paul M. Ridker
Brendan M. Everett
Aruna Pradhan
Jean G. MacFadyen
Daniel H. Solomon
Elaine Zaharris
Virak Mam
Ahmed Hasan
Yves Rosenberg
Erin Iturriaga
Milan Gupta
Michelle Tsigoulis
Subodh Verma
Michael B. Clearfield, Touro University CaliforniaFollow
Peter Libby
Samuel Z. Goldhaber
Roger Seagle
Cyril Ofori
Mohammad Saklayen
Samuel Butman

Publication Date

2-21-2019

DOI

10.1056/NEJMoa1809798

Publication Title

New England Journal of Medicine

Recommended Citation

Ridker, P. M., Everett, B. M., Pradhan, A., MacFadyen, J. G., Solomon, D. H., Zaharris, E., Mam, V., Hasan, A., Rosenberg, Y., Iturriaga, E., Gupta, M., Tsigoulis, M., Verma, S., Clearfield, M. B., Libby, P., Goldhaber, S. Z., Seagle, R., Ofori, C., Saklayen, M., … Glynn, R. J. (2019). Low-Dose Methotrexate for the Prevention of Atherosclerotic Events. New England Journal of Medicine, 380(8), 752–762. https://doi.org/10.1056/NEJMoa1809798

Comments

See the work itself for a complete list of authors. See here.